Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2025-12-25 @ 8:03 PM
Study NCT ID:
NCT05901935
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-13
First Post:
2023-06-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
DP303c in Patients With HER2-positive Advanced Breast Cancer
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-04
First Submit QC Date:
None
Study First Post Date:
2023-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-04
Last Update Post Date:
2023-06-13
Last Update Post Date Type:
ACTUAL